Literature DB >> 17902069

Comparison between a case-matched analysis of left upper lobe trisegmentectomy and left upper lobectomy for small size lung cancer located in the upper division.

A Iwasaki1, W Hamanaka, T Hamada, M Hiratsuka, S Yamamoto, T Shiraishi, T Shirakusa.   

Abstract

BACKGROUND: Although an increasing number of approaches for pulmonary segmentectomy to treat early lung cancer are being used, there have been few reports on left upper lobe trisegmentectomy, which is midway between single segmentectomy and lobectomy, for lung cancer.
METHODS: We retrospectively reviewed the medical charts of 86 clinical stage I case-matched patients with a tumor size of less than 2.0 cm in diameter located in the left upper division who underwent resection between June 1998 and December 2005. The patients were divided into two groups as follows: LTS (31), left upper lobe trisegmentectomy; LUL (55), left upper lobectomy. We evaluated these groups with respect to several factors.
RESULTS: The characteristics of the two groups (LTS vs. LUL) demonstrated no significant differences with respect to gender, histological type, tumor size, or upstaging of pathological node, or the mode of video-assisted thoracic surgery (VATS). Patients with LTS had a significantly lower pulmonary function compared to the LUL group. There were no significant differences between the two groups with respect to factors such as blood loss and duration of chest tube drainage. Morbidity and recurrence rates did not differ between the two groups, and there was no mortality in our series. The overall survival rate at 5 years was 69.7 % in the LTS and 72.5 % in the LUL group. There was no significant difference in survival rates between the LTS and the LUL group after resection.
CONCLUSION: LTS may be suitable as a standard treatment if the tumor is small and the suspected margins are well away from the lingula.

Entities:  

Mesh:

Year:  2007        PMID: 17902069     DOI: 10.1055/s-2007-965406

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

1.  Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Benedetta Bedetti; Luca Bertolaccini; Raffaele Rocco; Joachim Schmidt; Piergiorgio Solli; Marco Scarci
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 2.  Sublobar resection for early-stage lung cancer.

Authors:  Hiroyuki Sakurai; Hisao Asamura
Journal:  Transl Lung Cancer Res       Date:  2014-06

Review 3.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

4.  Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer.

Authors:  Ryan A Macke; Matthew J Schuchert; David D Odell; David O Wilson; James D Luketich; Rodney J Landreneau
Journal:  J Cardiothorac Surg       Date:  2015-04-01       Impact factor: 1.637

Review 5.  [Clinical Advance of Sublobectomy for Early Stage Non-small Cell Lung Cancer].

Authors:  Hui Zhang; Yang Shen-Tu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-09-20

6.  The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.

Authors:  Jian Zheng; Xiong Ye; Yanan Liu; Yuxia Zhao; Mudan He; Hui Xiao
Journal:  BMC Cancer       Date:  2020-02-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.